Molecular characterization of ulcerative colitis-associated colorectal carcinomas

[1]  K. Sheahan,et al.  Personalised mapping of tumour development in synchronous colorectal cancer patients , 2020, npj Genomic Medicine.

[2]  H. Sørensen,et al.  Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study , 2020, The Lancet.

[3]  B. Ylstra,et al.  IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas. , 2020, Inflammatory bowel diseases.

[4]  N. Harpaz,et al.  Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study , 2019, Modern Pathology.

[5]  D. Hirsch.  [Colorectal tumor evolution in inflammatory bowel disease : Dynamics of genomic alterations and potential molecular markers to predict malignant progression]. , 2019, Der Pathologe.

[6]  A. Hart,et al.  781 – Quantifying Evolution of Early Dysplastic Lesions in Ulcerative Colitis Predicts Future Colorectal Cancer Risk , 2019, Gastroenterology.

[7]  E. Ruppin,et al.  Cancer-type specific aneuploidies hard-wire chromosome-wide gene expression patterns of their tissue of origin , 2019, bioRxiv.

[8]  Marc J. Williams,et al.  Evolutionary history of human colitis-associated colorectal cancer , 2018, Gut.

[9]  P. Meltzer,et al.  Dynamics of Genome Alterations in Crohn's Disease–Associated Colorectal Carcinogenesis , 2018, Clinical Cancer Research.

[10]  Martin L. Miller,et al.  Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease–Associated Colorectal Cancers , 2018, Clinical Cancer Research.

[11]  Ashton C. Berger,et al.  Genomic and Functional Approaches to Understanding Cancer Aneuploidy. , 2018, Cancer cell.

[12]  J. Ji,et al.  Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer , 2018, International journal of cancer.

[13]  Kathryn T. Baker,et al.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications , 2017, Carcinogenesis.

[14]  R. Medema,et al.  p53 Prohibits Propagation of Chromosome Segregation Errors that Produce Structural Aneuploidies. , 2017, Cell reports.

[15]  A. Hart,et al.  Clonal evolution of colorectal cancer in IBD , 2017, Nature Reviews Gastroenterology &Hepatology.

[16]  Mingming Jia,et al.  COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..

[17]  Zachary J. Heins,et al.  Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease. , 2016, Gastroenterology.

[18]  N. Schultz,et al.  Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures , 2016, Molecular systems biology.

[19]  T. Smyrk,et al.  A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis , 2016, Inflammatory bowel diseases.

[20]  M. Pittman,et al.  Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. , 2016, Gastroenterology.

[21]  Nicole Pfarr,et al.  Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies , 2016, Genes, chromosomes & cancer.

[22]  D. Iliopoulos,et al.  MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. , 2015, Gastroenterology.

[23]  Siân Jones,et al.  Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA , 2015, Nature Communications.

[24]  A. Hart,et al.  Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview , 2015, The American Journal of Gastroenterology.

[25]  Melissa J. Landrum,et al.  RefSeq: an update on mammalian reference sequences , 2013, Nucleic Acids Res..

[26]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[27]  Sean Davis,et al.  Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. , 2013, Cancer research.

[28]  M. V. van Oijen,et al.  Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-analysis of Population-based Cohort Studies , 2013, Inflammatory bowel diseases.

[29]  Giovanni Parmigiani,et al.  Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.

[30]  M. Meyerson,et al.  Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. , 2012, Cancer research.

[31]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[32]  L. Peyrin-Biroulet,et al.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  T. Ried,et al.  A new whole genome amplification method for studying clonal evolution patterns in malignant colorectal polyps , 2012, Genes, chromosomes & cancer.

[34]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[35]  S. Itzkowitz,et al.  Intestinal inflammation and cancer. , 2011, Gastroenterology.

[36]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[37]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[38]  N. Harpaz,et al.  Colorectal dysplasia in chronic inflammatory bowel disease: pathology, clinical implications, and pathogenesis. , 2010, Archives of pathology & laboratory medicine.

[39]  Duane A. Compton,et al.  Proliferation of aneuploid human cells is limited by a p53-dependent mechanism , 2010, The Journal of cell biology.

[40]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[41]  M. Bronner,et al.  Clonal expansions in ulcerative colitis identify patients with neoplasia , 2009, Proceedings of the National Academy of Sciences.

[42]  N. Shepherd,et al.  Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. , 2009, Gastroenterology.

[43]  N. Harpaz,et al.  Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. , 2007, Gastroenterology.

[44]  H. Tanke,et al.  Chromosomal and Microsatellite Instability of Adenocarcinomas and Dysplastic Lesions (DALM) in Ulcerative Colitis , 2006, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[45]  Noam Harpaz,et al.  Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. , 2004, Gastroenterology.

[46]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[47]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[48]  T. Ried,et al.  Pronounced chromosomal instability and multiple gene amplifications characterize ulcerative colitis-associated colorectal carcinomas. , 2003, Cancer genetics and cytogenetics.

[49]  A. Walch,et al.  Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms. , 2003, The American journal of pathology.

[50]  J. Potter,et al.  Chromosomal instability in ulcerative colitis is related to telomere shortening , 2002, Nature Genetics.

[51]  C. Fenoglio-Preiser,et al.  A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene , 2001, Histopathology.

[52]  M. Bronner,et al.  Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. , 1999, Cancer research.

[53]  R. Machinami,et al.  p53 immunohistochemistry of ulcerative colitis‐associated with dysplasia and carcinoma , 1999, Pathology international.

[54]  E. Schröck,et al.  Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation , 1999, Genes, chromosomes & cancer.

[55]  J. Goldblum,et al.  Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis , 1999, American Journal of Gastroenterology.

[56]  S. Knuutila,et al.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.

[57]  M. Gregor,et al.  Comparative analysis of histology, DNA content, p53 and Ki‐ ras mutations in colectomy specimens with long‐standing ulcerative colitis , 1998, International journal of cancer.

[58]  O. Kallioniemi,et al.  Genome screening by comparative genomic hybridization. , 1997, Trends in genetics : TIG.

[59]  A. Ekbom,et al.  Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study , 1997, Gut.

[60]  F. Waldman,et al.  Chromosomal alterations in ulcerative colitis-related neoplastic progression. , 1997, Gastroenterology.

[61]  I. Talbot,et al.  Colorectal cancer in idiopathic inflammatory bowel disease. , 1996, Seminars in diagnostic pathology.

[62]  D. Ledbetter,et al.  Multicolor Spectral Karyotyping of Human Chromosomes , 1996, Science.

[63]  Thomas Ried,et al.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors , 1996, Genes, chromosomes & cancer.

[64]  D. Ward,et al.  Karyotyping human chromosomes by combinatorial multi-fluor FISH , 1996, Nature Genetics.

[65]  P. Rabinovitch,et al.  Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. , 1994, Gastroenterology.

[66]  P. Choi,et al.  Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. , 1994, Gut.

[67]  C. Bernstein,et al.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.

[68]  M. Kimmey,et al.  DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. , 1992, Gastroenterology.

[69]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[70]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[71]  A. Marx,et al.  MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. , 2010, The American journal of pathology.

[72]  L. Bolund,et al.  A strategy combining flow sorting and comparative genomic hybridization for studying genetic aberrations at different stages of colorectal tumorigenesis in ulcerative colitis. , 2001, Cytometry.

[73]  F. Waldman,et al.  Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization. , 2000, Human pathology.

[74]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.